Family and friends gathered at the University of Miami Life Science and Technology Park Wednesday morning to remember Tuly Gonzalez on what would have been her 32nd birthday. She died 11 years ago but the gathering was not just to remember her, but to also celebrate the lives she has impacted though her donation. [...]
In this exclusive video from The Liver Meeting 2019, Tarek Hassanein, MD, FAASLD, professor of medicine at UC San Diego Health and medical director of Southern California GI and Liver Centers, discusses results of a phase 2a study, which demonstrated that DUR-928 was well-tolerated and effective in patients with acute alcoholic hepatitis.
In the OPTIC trial, patients with wet age-related macular degeneration who were treated with ADVM-022, an intravitreal gene therapy, did not require additional injections following treatment, according to a presenter at the American Academy of Ophthalmology annual meeting.
There is amazing new technology that’s helping surgeons perform the most delicate of all operations — brain surgery. It saved the life of a Westchester County teenager whose headaches were from a brain tumor, CBS2’s Dr. Max Gomez reported Tuesday.
Warren Huff, Reata Pharma CEO, joins CNBC's "Power Lunch" team to discuss his company's positive clinical trial results for a drug to treat the neuromuscular disease Friedreich's ataxia.
Jim Cramer chats with Arrowhead Pharmaceuticals CEO Christopher Anzalone about projects the company is working on to silence genes that cause rare genetic disorders.
At the American Society of Retina Specialists meeting, Michael Stewart, MD, chairman and professor of ophthalmology at the Mayo Clinic of Jacksonville, Florida, discusses phase 2 results of AKST4290 (Alkahest), an orally administered small molecule CCR3 inhibitor.
At the 2019 American Headache Society Annual Meeting, July 11-14, in Philadelphia, Pennsylvania, one of the topics of focus among the newly approved therapies for migraine was the use of devices to treat the condition acutely. As such, a number of companies presented data on neuromodulation and neurostimulation devices—including electroCore, which has undergone the development [...]
Watch "Ronnie Andrews On Developing New Ways To Test For Lung Cancer", an archived episode of The Watch List originally aired 07/15/2019 on the TD Ameritrade Network.
Reata is in its 'final pivotal study' for its new drug, bardoxolone. In the trials, the drug has showed promising results to reverse kidney damage. Yahoo Finance sits down with the CEO of Reata, Warren Huff, who founded the company in 2002, to discuss the plans to launch the product in the near future. [...]
Nick Vita, CEO and co-founder of medical cannabis company Columbia Care, talks about being acquired by Canaccord Genuity Growth Corp. and what it will allow the company to do.
Reata CEO Warren Huff discusses his company's new drug, which has shown signs it can reverse kidney damage.
NEW YORK (NBC News) A peek inside the Friednman family's kitchen leaves one seeing double. There are two microwaves, two toasters and two different pantries. It's how the family separates the family's meals from the gluten-free foods necessary for their 15-year-old son Tyler, who has celiac disease. "He can go in there and get [...]
Biotech company OncoCyte is using a liquid biopsy to detect lung cancer that is showing promising results. Yahoo Finance’s Alexis Christoforous speaks to William Annett, the CEO of Oncocyte.
CBD oil falls into a gray area that might be legal in some states now because it is not psychoactive.
Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.
Patrik De Haes, MD, CEO of Oxurion, discusses the company’s three disease-modifying drug candidates for the treatment of diabetic eye disease with EyeWire News at the Ophthalmology Innovation Summit in Chicago.
Elad Kedar, CEO of Orasis Pharmaceuticals, provides a company update at OIS@AAO 2018 in Chicago.
CHICAGO: At the Ophthalmology Innovation Summit at AAO, Patrik De Haes, MD, CEO of Oxurion, introduces the company’s new clinical portfolio with three separate molecules in clinical trials for the treatment of diabetic macular edema.
Researchers are testing a new transdermal patch from Zosano Pharma that could deliver treatment for migraines.
Columbia Care is the largest multi-state medical cannabis operator in the United States. With a total of 33 licenses in 13 states, the company is looking to make an impact in the global cannabis industry by partnering with Canaccord Genuity Growth. Nicholas Vita, CEO and co-founder of Columbia Care, joins Cheddar to discuss. [...]
Nicholas Vita, Columbia Care CEO, discusses how Canada's legalization of recreational marijuana on Wednesday will affect the medicinal use market and how it may influence U.S.-based regulations.
It's a battle that has been raging for decades - the battle against Lyme Disease. Over the years, progress has been made against this dreaded tick-borne illness. But with breakthroughs come even more barriers. Watch this early peek at a new Fox 5 News special on the fight that could be signaling a new [...]
“We’re studying a medicine called bardoxolone methyl. It’s made by a company called Reata,” explained Block. Hinerfeld was the first person with Alport Syndrome to try bardoxolone. Block said, after 12 weeks, Hinerfeld’s kidney function stopped declining and actually improved.
At the American Headache Society’s 60th Annual Scientific Meeting, Dr. Alan Rapoport summarizes a poster he presented regarding ZOTRIP, Zosano Pharma’s zolmitriptan patch.
Columbia Care is set to open Kent County’s first medical marijuana dispensary on Friday.
Listen up! People are starting to hear, pay attention to, and react to the growing problem of hearing loss and other conditions of the inner ear. Nawal Ouzren explains how her company, Sensorion, is working to address the issue.
Looking at the performance of Arena Pharmaceuticals with CEO Amit Munshi and CNBC's Meg Tirrell.
